Gene Query: YIF1A

Dataset Description Geneva Score
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 66.92
MYCi361 regulates MYC target genes 27.17
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 23.4
Global analyses of the effect of different cellular contexts on microRNA targeting 23.04
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 23.04
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 20.31
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 17.96
Genome wide expression change by RNF168 knocking down in MCF-7 cells 16.8
Regulation of highly expressed hCINAP on translatome 16.53
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 16.27
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 16.02
KLF6-dependent transcription in renal cancer cells 14.39
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 14.38
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 14.13
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 13.78
RNA Seq of HMVEC under hypoxia 13.69
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 13.69
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 13.65
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 13.19
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 12.99
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 12.28
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 12.28
Identification of transcription start sites for human A549 cell line using ReCappable-seq 12.08
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 11.97
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 11.96
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 11.81
Effect of mitochondria deficiency on senescence-associated gene expression 11.78
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 11.76
The role of FAM46C in myeloma cells [sequencing] 11.72
The role of FAM46C in myeloma cells 11.72
Global analysis of enhancer targets: Mosaic-seq 11.49
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 11.49
In situ CAPTURE of chromatin interactions by biotinylated dCas9 11.49
NRDE2 negatively regulates nuclear exosome functions 11.47
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 11.4
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 11.37
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 11.33
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.19
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 11.03
The comparison of high-throughput single-cell RNA-seq methods 11.0
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 10.97
hTERT promotes cell adhesion and migration independent of telomerase activity 10.81
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 10.57
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 10.55
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 10.5
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 10.3
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 10.24
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 10.24
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 10.06
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.94
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 9.9
Gene Expression Profiling of SPOP Knocked Down Cell 9.84
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 9.73
Dtx3L and Androgen Signaling in Prostate Cancer 9.72
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 9.62
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 9.55
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 9.5
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 9.45
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 9.35
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 9.27
Inhibition of TNBC metastasis by Gpx1 9.14
Genome-wide transcriptional response to random aneuploidy in human cells 9.07
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 9.06
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 9.06
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 9.06
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 9.05
An RNA-centric dissection of host complexes controlling flavivirus infection 9.03
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 9.03
Uridylation by TUT4 and TUT7 marks mRNA for degradation 8.99
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 8.88
scRNASeq analysis of cycling cardiomyocytes 8.87
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.87
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 8.84
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 8.75
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 8.71
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 8.67
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 8.57
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.54
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 8.47
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.46
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.46
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 8.44
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 8.34
Mitochondrial dsRNA triggers antiviral signalling in humans 8.3
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 8.16
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 8.13
U1 snRNP telescripting regulates size-function stratified human genome 8.11
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.99
Mapping interactions for the TNIP2 hub protein 7.9
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 7.84
ARS2 is a general suppressor of pervasive transcription [RNAseq] 7.79
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 7.79
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 7.79
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 7.74
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 7.72
RNA-seq in transgenic cells 7.71
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 7.66
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 7.66
Human Treg IL-12 stimulation 7.61
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 7.6
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 7.57
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.57
Impact of dieldrin on transcription in Jurkat T cells 7.48
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 7.32
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 7.32
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.32
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 7.32
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.26
Transcriptome analysis in Neobractatin treated cells 7.23
The human blood-nerve barrier transcriptome 7.19
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 7.19
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 7.19
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 7.19
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.16
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 7.13
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 7.13
Silencing p300 in MCF7 cells to study expression and alternative splicing 7.08
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 7.07
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 7.06
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.03
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 7.01
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 7.0
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 7.0
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 6.94
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.93
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.93
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 6.91
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 6.89
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 6.86
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.84
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.82
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 6.78
Modeling Familial Cancer with iPSC Approaches 6.78
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 6.74
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 6.71
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 6.71
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 6.71
TCF7L1 knockdown in pancreatic cancer 6.69
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 6.68
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.68
Paxillin regulates genomic networks in prostate cancer [LNCaP] 6.67
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.61
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 6.6
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 6.48
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 6.47
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 6.46
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.43
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.43
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 6.41
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 6.41
Identification of HOXB13 target genes responsive to BET inhibitors 6.4
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.38
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 6.37
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 6.32
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 6.28
A role for ZNF598 in post-transcriptional gene regulation 6.27
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 6.27
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.21
TGF-β regulation of miRNA expression in pancreatic cancer 6.21
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 6.19
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 6.16
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.15
TGF-β promotes genomic instability after loss of RUNX3 6.12
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 6.12
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 6.11
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 6.1
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 6.06
DJ-1 is dispensable for human stem cell homeostasis 6.05
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.03
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.02
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 6.0
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 5.98
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 5.96
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 5.96
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 5.92
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 5.91
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 5.9
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.88
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 5.83
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.82
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 5.79
Survival of pancreatic cancer cells lacking KRAS function 5.77
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.75
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 5.73
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.73
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 5.73
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 5.73
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.72
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 5.69
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 5.68
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 5.64
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 5.64
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 5.63
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.63
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.6
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 5.59
X-Ray induced DNA-Hydroxymethylation changes 5.55
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.55
Effect of CHKA knockdown on C4-2 cell transcriptome 5.55
Role for citron kinase in prostate cancer growth 5.55
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 5.54
Accurate annotation of human protein-coding small open reading frames 5.53
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.52
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.5
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 5.5
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 5.47
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.43
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 5.4
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 5.4
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 5.4
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 5.38
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 5.31
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 5.3
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 5.3
RNA-seq of cells with TET1 knockout 5.27
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 5.27
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 5.27
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.26
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 5.24
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 5.21
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 5.21
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 5.2
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.19
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 5.18
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 5.16
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 5.16
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 5.11
RNAseq of cell lines with knocked in ESR1 mutations 5.09
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.07
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.07
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.07
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 5.04
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.04
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.02
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 5.0
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.99
Identification of global XBP1s target gene expression in human prostate cancer cells 4.99
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 4.99
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 4.98
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 4.96
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 4.96
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.96
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 4.95
Single-cell analysis of human kidney organoids 4.91
Illumina Total RNA-seq in HeLa 4.91
Identification of Sin3B regulated genes during quiescence 4.88
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 4.88
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.87
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 4.85
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.85
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 4.84
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.8
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.8
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 4.8
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 4.8
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 4.8
TT-Seq captures the human transient transcriptome 4.78
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.73
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.73
SUV420H2 knockdown in PANC-1 4.7
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 4.7
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 4.65
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.64
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 4.62
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.61
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 4.58
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 4.57
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 4.48
RNA-seq of shEZH2 cells 4.48
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.44
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.44
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 4.43
Hepatitis C virus functionally sequesters miR-122 4.39
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.39
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  4.39
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.34
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.34
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.28
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 4.27
Cajal bodies are linked to genome conformation 4.26
Cajal bodies are linked to genome conformation [RNA-Seq] 4.26
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 4.25
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 4.25
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 4.22
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 4.19
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 4.19
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 4.19
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 4.18
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.17
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 4.15
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 4.11
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 4.08
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 4.06
Mutational landscape of splicing genes and functional consequences across 33 cancer types 4.05
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.03
Gene expression signatures of innate lymphoid cells from human blood 4.02
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 4.0
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.98
RNA-seq of IL-4 stimulated human keratinocytes 3.94
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.9
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.85
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.85
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 3.84
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.84
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.84
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.82
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.82
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.81
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.77
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.75
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 3.72
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 3.72
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.68
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.66
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.64
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 3.64
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 3.64
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 3.64
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.6
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.58
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.56
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.56
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 3.49
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 3.49
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 3.49
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.48
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 3.48
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.47
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 3.41
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.37
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 3.36
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 3.35
K562 polyA RNA-Seq 3.32
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.31
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.31
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.31
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 3.3
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 3.25
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 3.22
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.22
Evaluating pre-clinical models for studying NASH driven HCC. 3.19
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.16
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 3.09
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.07
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.05
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 3.04
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.03
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.0
RNA editing in nascent RNA affects pre-mRNA splicing 2.98
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.97
The effect of Abl kinases on non-small cell carcinoma global transcriptome 2.94
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.9
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.89
Differential gene expression profiles in imatinib-resistant cell lines 2.88
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.85
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 2.84
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 2.84
Transcriptomic analysis of human tonsillar TFH subsets 2.82
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.8
Human Treg NaCl stimulation 2.77
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.7
SRSF1 role in cellular gene expression and splicing 2.68
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 2.66
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 2.57
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.55
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.52
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.52
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 2.49
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.48
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.48
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.44
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.43
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.43
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 2.41
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 2.39
Functional Haploid Human Oocytes Generated from Polar Body Genomes 2.39
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 2.38
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 2.28
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.25
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.24
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.21
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.1
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.07
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.02
Identification of a LIF-responsive replication-competent human β cell 2.02
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 1.99
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.94
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 1.93
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.87
RNA-sequencing of healthy human skeletal myocytes 1.84
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.82
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.8
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.78
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.76
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.64
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.6
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.59
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.56
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 1.55
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.55
RNA expression analysis upon JMJD1C depletion 1.55
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.52
Metabolism as an early predictor of DPSCs aging 1.49
EGR1-controlled transcriptome of T HESCs 1.46
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 1.46
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.46
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 1.42
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.41
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.41
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.41
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.38
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.37
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.34
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.34
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.3
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.29
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.29
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.27
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.23
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.23
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.2
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.19
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.19
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.17
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.16
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.02
Copper Regulation of HIF-1 Transcription Activity 1.02
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.02
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.0
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.0
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.97
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.93
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.92
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.92
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.91
miRNAs affected by antagomiR-17 treatment 0.9
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.9
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.88
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.87
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.86
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.85
RNA-Seq of PRMT1 overexpression ECA109 cells 0.84
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.81
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.76
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.74
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.74
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.72
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.69
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.69
Human Treg IFNg/IL-10 subpopulations 0.64
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.62
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.58
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.58
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.58
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.54
Comparative Analysis of Cas9 Activators Across Multiple Species 0.53
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.53
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.51
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.45
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.43
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.43
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.42
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.41
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 0.41
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.4
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.39
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.39
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.38
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.37
Downregulation of LATS kinases alters p53 to promote cell migration 0.36
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.36
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.36
Investigate A2M treatment on human prostate cancer and mouse liver 0.32
Investigate A2M treatment on human prostate cancer xenograft in mice 0.32
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.3
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.3
Enhancer activation during EGF response 0.29
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.29
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.29
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.28
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.27
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.26
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.26
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.25
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.24
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.24
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.13
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.12
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.12
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.12
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.12
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.12
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.1
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.1
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.08
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.08
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.05
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.05
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.04
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation